183 related articles for article (PubMed ID: 19437111)
1. Cysteamine prevents inhibition of adenylate kinase caused by cystine in rat brain cortex.
Figueiredo VC; Feksa LR; Wannmacher CM
Metab Brain Dis; 2009 Dec; 24(4):723-31. PubMed ID: 19437111
[TBL] [Abstract][Full Text] [Related]
2. Cysteamine prevents inhibition of adenylate kinase caused by cystine in rat brain cortex.
Figueiredo VC; Feksa LR; Wannmacher CM
Metab Brain Dis; 2009 Sep; 24(3):373-81. PubMed ID: 19688256
[TBL] [Abstract][Full Text] [Related]
3. Cysteamine prevents inhibition of thiol-containing enzymes caused by cystine or cystine dimethylester loading in rat brain cortex.
Rech VC; Feksa LR; Fleck RM; Athaydes GA; Dornelles PK; Rodrigues-Junior V; Wannmacher CM
Metab Brain Dis; 2008 Jun; 23(2):133-45. PubMed ID: 18418703
[TBL] [Abstract][Full Text] [Related]
4. Cysteamine prevents and reverses the inhibition of creatine kinase activity caused by cystine in rat brain cortex.
Fleck RM; Rodrigues Junior V; Giacomazzi J; Parissoto D; Dutra-Filho CS; de Souza Wyse AT; Wajner M; Wannmacher CM
Neurochem Int; 2005 Apr; 46(5):391-7. PubMed ID: 15737437
[TBL] [Abstract][Full Text] [Related]
5. Thiol/disulfide status regulates the activity of thiol-containing kinases related to energy homeostasis in rat kidney.
Rech VC; Mezzomo NJ; Athaydes GA; Feksa LR; Figueiredo VC; Kessler A; Franceschi ID; Wannmacher CMD
An Acad Bras Cienc; 2018; 90(1):99-108. PubMed ID: 29236866
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of creatine kinase activity by cystine in the kidney of young rats.
Rech VC; Athaydes GA; Feksa LR; Dornelles PK; Rodrigues-Junior V; Dutra-Filho CS; De Souza Wyse AT; Wajner M; Wannmacher CM
Pediatr Res; 2006 Aug; 60(2):190-5. PubMed ID: 16864702
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant effect of cysteamine in brain cortex of young rats.
Kessler A; Biasibetti M; da Silva Melo DA; Wajner M; Dutra-Filho CS; de Souza Wyse AT; Wannmacher CM
Neurochem Res; 2008 May; 33(5):737-44. PubMed ID: 17940891
[TBL] [Abstract][Full Text] [Related]
8. Cysteamine prevents and reverses the inhibition of pyruvate kinase activity caused by cystine in rat heart.
Rosa TG; de Souza Wyse AT; Wajner M; Wannmacher CM
Biochim Biophys Acta; 2004 Jun; 1689(2):114-9. PubMed ID: 15196592
[TBL] [Abstract][Full Text] [Related]
9. Cystine inhibits creatine kinase activity in pig retina.
Pereira Oliveira PR; Rodrigues-Junior V; Rech VC; Duval Wannmacher CM
Arch Med Res; 2007 Feb; 38(2):164-9. PubMed ID: 17227724
[TBL] [Abstract][Full Text] [Related]
10. Promotion of oxidative stress in kidney of rats loaded with cystine dimethyl ester.
Rech VC; Feksa LR; Arevalo do Amaral MF; Koch GW; Wajner M; Dutra-Filho CS; Terezinha de Souza Wyse A; Duval Wannmacher CM
Pediatr Nephrol; 2007 Aug; 22(8):1121-8. PubMed ID: 17534668
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of pyruvate kinase activity by cystine in brain cortex of rats.
Feksa LR; Cornelio A; Dutra-Filho CS; De Souza Wyse AT; Wajner M; Wannmacher CM
Brain Res; 2004 Jun; 1012(1-2):93-100. PubMed ID: 15158165
[TBL] [Abstract][Full Text] [Related]
12. Effects of cysteamine on oxidative status in cerebral cortex of rats.
Kessler A; Biasibetti M; Feksa LR; Rech VC; Melo DA; Wajner M; Dutra-Filho CS; Wyse AT; Wannmacher CM
Metab Brain Dis; 2008 Mar; 23(1):81-93. PubMed ID: 18030610
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of NACA and diNACA in human cystinosis fibroblast cell cultures as potential treatments for cystinosis.
Hector E; Cairns D; Michael Wall G
Orphanet J Rare Dis; 2022 Jun; 17(1):231. PubMed ID: 35710564
[TBL] [Abstract][Full Text] [Related]
14. [From gene to disease: cystinosis].
Levtchenko EN; Wilmer M; de Graaf-Hess AC; van den Heuvel LP; Blom H; Monnens LA
Ned Tijdschr Geneeskd; 2004 Mar; 148(10):476-8. PubMed ID: 15042893
[TBL] [Abstract][Full Text] [Related]
15. Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis.
Hollywood JA; Przepiorski A; D'Souza RF; Sreebhavan S; Wolvetang EJ; Harrison PT; Davidson AJ; Holm TM
J Am Soc Nephrol; 2020 May; 31(5):962-982. PubMed ID: 32198276
[TBL] [Abstract][Full Text] [Related]
16. Cystine dimethylester model of cystinosis: still reliable?
Wilmer MJ; Willems PH; Verkaart S; Visch HJ; de Graaf-Hess A; Blom HJ; Monnens LA; van den Heuvel LP; Levtchenko EN
Pediatr Res; 2007 Aug; 62(2):151-5. PubMed ID: 17597653
[TBL] [Abstract][Full Text] [Related]
17. Strict cysteamine dose regimen is required to prevent nocturnal cystine accumulation in cystinosis.
Levtchenko EN; van Dael CM; de Graaf-Hess AC; Wilmer MJ; van den Heuvel LP; Monnens LA; Blom HJ
Pediatr Nephrol; 2006 Jan; 21(1):110-3. PubMed ID: 16252107
[TBL] [Abstract][Full Text] [Related]
18. NIH conference. Cystinosis: progress in a prototypic disease.
Gahl WA; Thoene JG; Schneider JA; O'Regan S; Kaiser-Kupfer MI; Kuwabara T
Ann Intern Med; 1988 Oct; 109(7):557-69. PubMed ID: 3048161
[TBL] [Abstract][Full Text] [Related]
19. [Cystinosis--an orphan disease. Pathogenesis and current treatment].
Zachwieja J
Przegl Lek; 2006; 63 Suppl 3():29-31. PubMed ID: 16898482
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal cystine storage in cystinosis and mucolipidosis type II.
Greene AA; Jonas AJ; Harms E; Smith ML; Pellett OL; Bump EA; Miller AL; Schneider JA
Pediatr Res; 1985 Nov; 19(11):1170-4. PubMed ID: 4069825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
